“…Packed red blood cells (RBCs) are transfused in 20-86% of patients in liver transplantation (LT) (1). A Cochrane review on methods for attenuating blood loss and decreasing transfusion requirements in LT concluded that antifibrinolytic therapy and use of viscoelastic point-of-care testing may potentially reduce blood loss and transfusion requirements, although they pointed out the need for welldesigned randomized trials (2).…”
“…Packed red blood cells (RBCs) are transfused in 20-86% of patients in liver transplantation (LT) (1). A Cochrane review on methods for attenuating blood loss and decreasing transfusion requirements in LT concluded that antifibrinolytic therapy and use of viscoelastic point-of-care testing may potentially reduce blood loss and transfusion requirements, although they pointed out the need for welldesigned randomized trials (2).…”
“…FIBTEM can be used to assess clot firmness and then fibrinogen therapy can be titrated [68]. Alternatively, when diffuse bleeding is detected, a plasma fibrinogen value b 1 g/L should be the aim [69].…”
Section: Anesthesia For the Intestinal Transplant Recipientmentioning
“…These include dissection or preanhepaticphase, anhepatic phase, post-reperfusion phase and early post-operative period [25]. In the anhepatic phase, no important surgical blood loss is usually seen because of appropriate clamping of vessels.…”
Section: Hemostasis During Liver Transplantationmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.